117 related articles for article (PubMed ID: 18715835)
1. Changes in PDGF concentration in surgically treated colorectal carcinoma.
Mantur M; Snarska J; Sidorska A; Ostrowska H; Kruszewska-Wnorowska K; Wojszel J
Adv Med Sci; 2008; 53(1):37-41. PubMed ID: 18715835
[TBL] [Abstract][Full Text] [Related]
2. Changes in platelet CD 62P expression and soluble P-selectin concentration in surgically treated colorectal carcinoma.
Dymicka-Piekarska V; Matowicka-Karna J; Osada J; Kemona H; Butkiewicz AM
Adv Med Sci; 2006; 51():304-8. PubMed ID: 17357330
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of PDGF-AB and sP-selectin concentrations in relation to platelet count in patients with colorectal cancer before and after surgical treatment.
Mantur M; Koper O; Snarska J; Sidorska A; Kruszewska-Wnorowska K
Pol Arch Med Wewn; 2008 Jun; 118(6):345-50. PubMed ID: 18619189
[TBL] [Abstract][Full Text] [Related]
4. Does colorectal cancer influence platelet activation?
Dymicka-Piekarska V; Kemona H; Piotrowski Z; Gryko M; Milewski Z; Matowicka-Karna J
Przegl Lek; 2003; 60(11):716-8. PubMed ID: 15058040
[TBL] [Abstract][Full Text] [Related]
5. Soluble P-selectin concentration in patients with colorectal cancer.
Dymicka-Piekarska V; Butkiewicz A; Matowicka-Karna J; Kemona H
Neoplasma; 2005; 52(4):297-301. PubMed ID: 16059645
[TBL] [Abstract][Full Text] [Related]
6. P53 correlates positively with VEGF in preoperative sera of colorectal cancer patients.
Famulski W; Sulkowska M; Wincewicz A; Kedra B; Pawlak K; Zalewski B; Sulkowski S; Koda M; Baltaziak M
Neoplasma; 2006; 53(1):43-8. PubMed ID: 16416012
[TBL] [Abstract][Full Text] [Related]
7. [Does colorectal cancer clinical advancement and surgical treatment affect platelet factor 4 concentration].
Dymicka-Piekarska V; Butkiewicz A; Kemona H; Gryko M; Mantur M
Pol Merkur Lekarski; 2004 Dec; 17(102):575-8. PubMed ID: 15771125
[TBL] [Abstract][Full Text] [Related]
8. [Serum concentration of insulin, C-peptide and insulin-like growth factor I in patients with colon adenomas and colorectal cancer].
Kaczka A; Kumor A; Pietruczuk M; Małecka-Panas E
Pol Merkur Lekarski; 2007 May; 22(131):373-5. PubMed ID: 17679371
[TBL] [Abstract][Full Text] [Related]
9. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
10. Increased serum angiogenin concentration in colorectal cancer is correlated with cancer progression.
Shimoyama S; Yamasaki K; Kawahara M; Kaminishi M
Clin Cancer Res; 1999 May; 5(5):1125-30. PubMed ID: 10353747
[TBL] [Abstract][Full Text] [Related]
11. Serum arginase activity in postsurgical monitoring of patients with colorectal carcinoma.
Porembska Z; Skwarek A; Mielczarek M; Barańczyk-Kuźma A
Cancer; 2002 Jun; 94(11):2930-4. PubMed ID: 12115381
[TBL] [Abstract][Full Text] [Related]
12. Gastrin levels in patients with colorectal cancer.
Fontanesi BV; Boris B; Delcio M; Manoukian FN
Hepatogastroenterology; 1997; 44(16):1082-4. PubMed ID: 9261603
[TBL] [Abstract][Full Text] [Related]
13. Utility of serum preoperative carcinoemberyonic antigen in colorectal cancer patients.
El-Awady S; Lithy R; Morshed M; Khafagy W; Abd Monem H; Waleed O; Badr S; Fekry A; El Nakeeb A; Ghazy H; El Yamany M; Metwally T; El-Arman M; Farid M
Hepatogastroenterology; 2009; 56(90):361-6. PubMed ID: 19579599
[TBL] [Abstract][Full Text] [Related]
14. Does surgery affect certain mediators of thrombocytopoiesis in patients with colorectal cancer?
Dymicka-Piekarska V; Kemona H; Guzinska-Ustymowicz K
Hepatogastroenterology; 2007; 54(77):1407-11. PubMed ID: 17708265
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the platelet concentrate collection system with the plasma-rich-in-growth-factors kit to produce platelet-rich plasma: a technical report.
Weibrich G; Kleis WK; Hitzler WE; Hafner G
Int J Oral Maxillofac Implants; 2005; 20(1):118-23. PubMed ID: 15747683
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients.
Szajda SD; Snarska J; Jankowska A; Roszkowska-Jakimiec W; Puchalski Z; Zwierz K
Hepatogastroenterology; 2008; 55(82-83):388-93. PubMed ID: 18613372
[TBL] [Abstract][Full Text] [Related]
17. Preoperative serum vascular endothelial growth factor-a is a marker for subsequent recurrence in colorectal cancer patients.
Alabi AA; Suppiah A; Madden LA; Monson JR; Greenman J
Dis Colon Rectum; 2009 May; 52(5):993-9. PubMed ID: 19502868
[TBL] [Abstract][Full Text] [Related]
18. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.
Tang R; Yeh CY; Wang JY; Changchien CR; Chen JS; Hsieh LL
Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
Miyazaki T; Okada N; Ishibashi K; Ogata K; Ohsawa T; Ishiguro T; Nakada H; Yokoyama M; Matsuki M; Kato H; Kuwano H; Ishida H
Jpn J Clin Oncol; 2008 Dec; 38(12):839-43. PubMed ID: 18923001
[TBL] [Abstract][Full Text] [Related]
20. Comparative studies of tissue inhibitor of metalloproteinases-1 in plasma, serum and tumour tissue extracts from patients with primary colorectal cancer.
Sørensen NM; Schrohl AS; Jensen V; Christensen IJ; Nielsen HJ; Brünner N
Scand J Gastroenterol; 2008; 43(2):186-91. PubMed ID: 18224564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
